Insulet
PODD
#1938
Rank
A$14.75 B
Marketcap
A$212.76
Share price
-1.85%
Change (1 day)
-55.26%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): A$0.81 Billion

According to Insulet's latest financial reports the company's current earnings are A$3.05 Billion. In 2025 the company made an earning of A$0.56 Billion, an increase over its 2024 earnings that were of A$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.81 B44.04%
2025 A$0.56 B16.3%
2024 A$0.48 B36.76%
2023 A$0.35 B481.9%
2022 A$61.26 M-45.24%
2021 A$0.11 B43.35%
2020 A$78.03 M18.51%
2019 A$65.84 M41.16%
2018 A$46.64 M-711.95%
2017 -A$7.63 Million-56.85%
2016 -A$17.67 Million-79.31%
2015 -A$85.41 Million63.85%
2014 -A$52.13 Million31.04%
2013 -A$39.78 Million-21.96%
2012 -A$50.98 Million
2010 -A$48.62 Million-42.38%
2009 -A$84.38 Million-33.56%
2008 -A$0.13 Billion65.93%
2007 -A$76.54 Million209.75%
2006 -A$24.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.25 B 4,635.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.56 B 1,370.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$10.41 B 1,224.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$47.75 B 5,970.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$86.7 Million-111.02%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
A$0.11 B-85.03%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$1.84 B 134.01%๐Ÿ‡บ๐Ÿ‡ธ USA